Literature DB >> 15076190

An age-related decline in endothelial function is not associated with alterations in L-arginine transport in humans.

Belinda A Ahlers1, Melinda M Parnell, Jaye P F Chin-Dusting, David M Kaye.   

Abstract

OBJECTIVES: Endothelial dysfunction is established in aged individuals; however, the mechanism(s) are not fully elucidated. We have previously identified l-arginine transport as a potential rate-limiting factor in nitric oxide (NO) production in heart-failure patients, characterized with endothelial dysfunction. We therefore aimed to investigate whether the age-related decline in endothelial function is due to reduced transport of the NO precursor, L-arginine.
METHODS: Thirty-seven healthy males aged between 19 and 69 were recruited. Throughout 40 min of intra-arterial (i.a.) infusion of [3H]L-arginine (100 nCi/min), venous blood samples were withdrawn for the determination of L-arginine clearance. Venous occlusion plethysmography was then used to record the forearm blood flow responses to i.a. infusions of acetylcholine (ACh; 9.25 and 37 microg/min) and sodium nitroprusside (SNP; 2 and 8 microg/min).
RESULTS: While ACh-induced vasodilation decreased with age (37 microg/min; young 15.87 +/- 1.30, middle-aged 9.59 +/- 1.33, older 10.42 +/- 1.12 ml/min per 100 ml tissue; P = 0.001), there was no change in forearm [3H]L-arginine clearance (young 126.08 +/- 19.05, middle-aged 122.47 +/- 20.96, older 126.56 +/- 19.56 ml/min; NS). Further [3H]L-arginine uptake studies in isolated peripheral blood mononuclear cells supported our in vivo findings, demonstrating no difference in [3H]L-arginine transport across the age spectrum.
CONCLUSIONS: The present study excludes the hypothesis of impaired L-arginine transport as a potential mechanism for the age-related decline in endothelial function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076190     DOI: 10.1097/00004872-200402000-00016

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

Review 1.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  Endothelium, aging, and hypertension.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Daniele Versari; Antonio Salvetti
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 3.  The impact of age on vascular smooth muscle function in humans.

Authors:  David Montero; Gary L Pierce; Coen D A Stehouwer; Jaume Padilla; Dick H J Thijssen
Journal:  J Hypertens       Date:  2015-03       Impact factor: 4.844

4.  Mechanisms involved in the aging-induced vascular dysfunction.

Authors:  Mariam El Assar; Javier Angulo; Susana Vallejo; Concepción Peiró; Carlos F Sánchez-Ferrer; Leocadio Rodríguez-Mañas
Journal:  Front Physiol       Date:  2012-05-28       Impact factor: 4.566

Review 5.  Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2009-12-15       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.